Shapira, S.; Kazanov, D.; Mdah, F.; Yaakobi, H.; Herishanu, Y.; Perry, C.; Avivi, I.; Itchaki, G.; Shacham-Abulafia, A.; Raanani, P.;
et al. Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies. J. Pers. Med. 2021, 11, 724.
https://doi.org/10.3390/jpm11080724
AMA Style
Shapira S, Kazanov D, Mdah F, Yaakobi H, Herishanu Y, Perry C, Avivi I, Itchaki G, Shacham-Abulafia A, Raanani P,
et al. Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies. Journal of Personalized Medicine. 2021; 11(8):724.
https://doi.org/10.3390/jpm11080724
Chicago/Turabian Style
Shapira, Shiran, Dina Kazanov, Fatin Mdah, Hadas Yaakobi, Yair Herishanu, Chava Perry, Irit Avivi, Gilad Itchaki, Adi Shacham-Abulafia, Pia Raanani,
and et al. 2021. "Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies" Journal of Personalized Medicine 11, no. 8: 724.
https://doi.org/10.3390/jpm11080724
APA Style
Shapira, S., Kazanov, D., Mdah, F., Yaakobi, H., Herishanu, Y., Perry, C., Avivi, I., Itchaki, G., Shacham-Abulafia, A., Raanani, P., Hay-Levy, M., Aiger, G., Mashiah, J., Lev-Ari, S., & Arber, N.
(2021). Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies. Journal of Personalized Medicine, 11(8), 724.
https://doi.org/10.3390/jpm11080724
